Trinity Biotech PLC

NASDAQ:TRIBUnited States

NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

Trinity Biotech PLC is an Ireland-based develops, acquires, manufactures and markets medical diagnostic systems, including both reagents and instrumentation for the clinical laboratory and point-of-care segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its segments include the Americas and Rest of World. It is a provider of raw materials to the life sciences and research industries globally. It also operates a licensed reference laboratory that specializes in diagnostics for autoimmune diseases. Its POC brands include Uni-Gold, Recombigen, MarDx, FlexTrans, Premier and Ultra. Its clinical laboratory brands include ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ. The Company manufactures kits for the detection of specialty and esoteric biomarkers of infectious diseases and other associated laboratory products.

Contact Information

Headquarters

Ida Business Park Bray, Co Wicklow, IrelandBRAY, Ireland 18

Phone

---

Fax

---

Executives

Non-Executive Director

Aris Kekedjian

Chief Executive Officer, Executive Director

Ronan O'caoimh

Chief Financial Officer, Executive Director, Company Secretary

John Gillard

Chief Technology Officer

Gary Keating

Chief Accounting Officer

Simon Dunne